Building The Team

When building a production line from lab-based processes, sometimes staff primarily familiar with research might not know the specifics of regulations relating to late-stage drug production. During this segment of Cell & Gene Live “Building An In-House Cell & Gene Manufacturing Facility – Best Practices & Lessons Learned”, panelists Will Junker, Head of Vector Manufacturing Quality at Kite Pharma and Mitch Lower, SVP of Technical Operations at Kriya Therapeutics talk us through how to build a team that has the skillset needed to run a GMP facility.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene